Literature DB >> 11061492

Editorial: cardiovascular disease in primary hyperparathyroidism.

S J Silverberg.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11061492     DOI： 10.1210/jcem.85.10.6927

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  4 in total

1.  Evaluation of subclinical coronary atherosclerosis in mild asymptomatic primary hyperparathyroidism patients.

Authors:  Alper Kepez; Ayla Harmanci; Tuncay Hazirolan; Mehlika Isildak; Ugur Kocabas; Ahmet Ates; Orcun Ciftci; Lale Tokgozoglu; Alper Gürlek
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-11       Impact factor: 2.357

2.  Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism.

Authors:  Merih Baykan; Cihangir Erem; Turan Erdoğan; Arif Hacihasanoğlu; Omer Gedikli; Abdulkadir Kiriş; Mehmet Küçükosmanoğlu; Halil Onder Ersöz; Sükrü Celik
Journal:  Int J Cardiovasc Imaging       Date:  2006-10-12       Impact factor: 2.316

3.  Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism.

Authors:  P D Broulik; A Brouliková; S Adámek; P Libanský; J Tvrdoň; K Broulikova; J Kubinyi
Journal:  Int J Endocrinol       Date:  2011-02-20       Impact factor: 3.257

4.  Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary Results.

Authors:  Petramala Luigi; Formicuccia Maria Chiara; Zinnamosca Laura; Marinelli Cristiano; Cilenti Giuseppina; Colangelo Luciano; Panzironi Giuseppe; Cerci Sabrina; Sciomer Susanna; Ciardi Antonio; Cavallaro Giuseppe; De Toma Giorgio; Letizia Claudio
Journal:  Int J Endocrinol       Date:  2012-06-07       Impact factor: 3.257
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.